60 Plus, Leading Senior Citizen Group, Praises Pfizer Prescription Drug Plan
The 60 Plus Association, a half million member senior citizen lobbying group, today called a new Pfizer prescription drug program to be offered at low cost to the 7 million seniors most in need a major step toward solving America’s prescription drug problem.